Sionna Therapeutics, Inc.
SION
$42.18
-$0.59-1.38%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 25.96% | 8.80% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 25.36% | -0.81% | |||
| Operating Income | -25.36% | 0.81% | |||
| Income Before Tax | -31.01% | -0.80% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -31.01% | -0.80% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -31.01% | -0.80% | |||
| EBIT | -25.36% | 0.81% | |||
| EBITDA | -25.51% | 0.66% | |||
| EPS Basic | -30.18% | 0.07% | |||
| Normalized Basic EPS | -30.19% | 0.07% | |||
| EPS Diluted | -30.18% | 0.07% | |||
| Normalized Diluted EPS | -30.19% | 0.07% | |||
| Average Basic Shares Outstanding | 0.64% | 0.86% | |||
| Average Diluted Shares Outstanding | 0.64% | 0.86% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||